NEW YORK, Nov. 9 (GenomeWeb News) - The European Molecular Biology Laboratory and Abnova of Taiwan will join forces to produce monoclonal antibodies in high throughput, the two partners said today.
EMBL will contribute technologies relating to automation and monoclonal antibody production developed at its Monoclonal Core Facility in
EMBL Enterprise Management and Abnova also plan to collaborate in marketing a custom OEM monoclonal antibody service. Abnova has formed a subsidiary in Germany to expand the custom service for academic and industrial researchers.
Abnova said it is currently developing an antibody catalog for drug discovery and diagnostics, focusing on antibodies against human kinases, receptors, apoptosis proteins, stem cell proteins, and plasma proteins.